G, A., A, B., L, V., G, T., B, G., M, R., . . . SM, F. (2025). Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis. Clinical and experimental dermatology, 50(11), 2211. https://doi.org/10.1093/ced/llaf302
Chicago Style (17th ed.) CitationG, Avallone, et al. "Therapeutic Outcomes Across Janus Kinase Inhibitors In prurigo Nodularis." Clinical and Experimental Dermatology 50, no. 11 (2025): 2211. https://doi.org/10.1093/ced/llaf302.
MLA (9th ed.) CitationG, Avallone, et al. "Therapeutic Outcomes Across Janus Kinase Inhibitors In prurigo Nodularis." Clinical and Experimental Dermatology, vol. 50, no. 11, 2025, p. 2211, https://doi.org/10.1093/ced/llaf302.
Warning: These citations may not always be 100% accurate.